Autism Spectrum Disorder — Neuro Strengths-Based Approach to Autism
Citation(s)
American Psychiatric Association Diagnostic and statistical manual of mental disorders. Washington DC: American Psychiatric Association; 2013. 646
Donaldson A, Krejcha K, McMillin A A Strengths-Based Approach to Autism: Neurodiversity and Partnering With the Autism Community. Perspectives of the ASHA Special Interest Groups (2017) 2(1) 56-68
Ha S, Sohn IJ, Kim N, Sim HJ, Cheon KA Characteristics of Brains in Autism Spectrum Disorder: Structure, Function and Connectivity across the Lifespan. Exp Neurobiol. 2015 Dec;24(4):273-84. doi: 10.5607/en.2015.24.4.273. Epub 2015 Dec 16.
Leadbitter K, Buckle KL, Ellis C, Dekker M Autistic Self-Advocacy and the Neurodiversity Movement: Implications for Autism Early Intervention Research and Practice. Front Psychol. 2021 Apr 12;12:635690. doi: 10.3389/fpsyg.2021.635690. eCollection 2021.
Patten Koenig K A strength-based frame of reference for autistic individuals. Frames of reference for pediatric occupational therapy (4th edition) (2019)
Patten Koenig K Authentic Strength-Based Practice: Can Neurotypical Professionals Make a Paradigm Shift? Autism Spectrum News (2020) (Winter)
Wolff, Michael (2018). The Complexity of Autism Spectrum Disorders
Wozniak RH, Leezenbaum NB, Northrup JB, West KL, Iverson JM The development of autism spectrum disorders: variability and causal complexity. Wiley Interdiscip Rev Cogn Sci. 2017 Jan;8(1-2):10.1002/wcs.1426. doi: 10.1002/wcs.1426. Epub 2016 Dec 1.
Training in Neuro Strengths-Based Approach to Autism
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
